The first synthesis of the antiinflammatory marine natural product luffariellolide has been achieved by a convergent pathway involving sp3-sp3 cross-coupling and silyloxyfuran oxyfunctionalisation as key steps. An illustration of the inherent flexibility of this strategy is provided by a simple synthesis of α,β-acariolide and its γ-hydroxylated derivative from a common silyloxyfuran precursor.
抗炎海洋
天然产物luffariellolide的首次合成已经通过一种收敛路径实现,该路径涉及sp3-sp3交叉耦合和silyloxyfuran氧功能化作为关键步骤。这一策略固有的灵活性通过从一个共同的silyloxyfuran前体简单合成α,β-acariolide及其γ-羟基衍
生物得到了体现。